Impact of Ki67 and progesterone receptor on PFS with cyclin-dependent kinase 4/6 inhibitors in HER2-negative advanced breast cancer: A real world mono-institutional experience. (October 2020) - Palleschi, M.; Barzotti, E.; Melegari, E.; Manunta, S.; Mannozzi, F.; Vagheggini, A.; Maltoni, R.; Fedeli, A.; Sarti, S.; Cecconetto, L.; Possanzini, P.; Ravaioli, S.; et al.